(Total Views: 571)
Posted On: 01/21/2021 4:04:52 PM
Post# of 145871
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Just released by the Biden admin. on WhiteHouse.gov.
Prioritize therapeutics and establish a comprehensive, integrated COVID-19
treatment discovery and development program.
Effective treatments for COVID-19
are critical to saving lives. The federal government will establish a comprehensive,
integrated, and coordinated preclinical drug discovery and development program,
with diverse clinical trials, to allow therapeutics to be evaluated and developed
rapidly in response to COVID-19 and other pandemic threats. This includes promoting
the immediate and rapid development of therapeutics that respond to COVID-19
by developing new antivirals directed against the coronavirus family, accelerating
research and support for clinical trials for therapeutics in response to COVID-19
with a focus on those that can be readily scaled and administered, and developing
broad-spectrum antivirals to prevent future viral pandemics. President Biden issued
Executive Order Improving and Expanding Access to Care and Treatment for COVID-19
which also outlines steps to bolster clinical care capacity, provide assistance to
long-term care facilities and intermediate care facilities for people with disabilities,
increase health care workforce capacity, expand access to programs designed to
meet long-term health needs of patients recovering from COVID-19, and support
access to safe and effective COVID-19 therapies for those without coverage
Prioritize therapeutics and establish a comprehensive, integrated COVID-19
treatment discovery and development program.
Effective treatments for COVID-19
are critical to saving lives. The federal government will establish a comprehensive,
integrated, and coordinated preclinical drug discovery and development program,
with diverse clinical trials, to allow therapeutics to be evaluated and developed
rapidly in response to COVID-19 and other pandemic threats. This includes promoting
the immediate and rapid development of therapeutics that respond to COVID-19
by developing new antivirals directed against the coronavirus family, accelerating
research and support for clinical trials for therapeutics in response to COVID-19
with a focus on those that can be readily scaled and administered, and developing
broad-spectrum antivirals to prevent future viral pandemics. President Biden issued
Executive Order Improving and Expanding Access to Care and Treatment for COVID-19
which also outlines steps to bolster clinical care capacity, provide assistance to
long-term care facilities and intermediate care facilities for people with disabilities,
increase health care workforce capacity, expand access to programs designed to
meet long-term health needs of patients recovering from COVID-19, and support
access to safe and effective COVID-19 therapies for those without coverage
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)